Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation

Hepatology

Volumn 25, Issue 3, 1997, Pages 683-688

  Segal, Helen ^a   Cottam, Simon ^b   Potter, Dennis ^b   Hunt, Beverley J ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 12A; COMPLEMENT COMPONENT C1S INHIBITOR; FIBRINOGEN; KALLIKREIN; PLASMINOGEN; PREKALLIKREIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; THROMBIN TIME;

ADULT; BLOOD COAGULATION; FIBRINOLYSIS; HEMOSTASIS; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; LIVER TRANSPLANTATION; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0031048424     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250332     Document Type: Article

References (19)

1. Boks AL, Brommer EJP, Schalm SW, Van Vliet HHDM. Haemostasis and fibrinolysis in severe liver failure and their relation to haemorrhage. HEPATOLOGY 1986; 6:79-86.
2. Paramo JA, Kocha E. Haemostasis in advanced liver disease. Semin Thromb Haemost 1993; 19:184-190.
3. Cohen H, Hunt JB, Dixit D, Kanwar S, Thomas HC. Decreased contact factor mediated fibrinolysis in cirrhosis. Br J Haematol 1993;85:542-545.
4. Hersch SL, Kunelis T, Francis RB. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor. Blood 1987;69:1315-1319.
5. Kemkes-Matthes B, Bleyl H, Matthes KJ. Coagulation activation in liver disease. Thromb Res 1991;64:253-261.
6. Ritter MD, Owen CA, Bowie WEJ, Rettke SR, Cole TL, Taswell HF, Ilstrup DM, et al. Evaluation of preoperative haematology-coagulation screening in liver transplantation. Mayo Clin Proc 1989;64:216-223.
7. Mallett SV, Cox DJA. Thromboelastography [Review]. Br J Anaesth 1992; 69:307-313.
8. Palareti G, Legnani C, Maccaferri M, Gozzetti G, Mazziotti A, Martinelli G, Zanello M, et al. Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipients disease and use of antithrombin III concentrates. Haemostasis 1991;21:68-76.
9. Porte RJ, Bontempo FA, Knot AER, Lewis JH, Kang YG, Starzl TE. Systemic effects of tissue plasminogen activator associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989;47:978-984.
10. Schlesinger M, Benbassat C, Shoenfeld Y. Complement profile in primary biliary cirrhosis. Immunol Res 1992; 11:98-103.
11. Segal HC, Hunt BJ, Cottam S, Beard C, Francis JL, Potter D, Tan KC. Changes in the contact system during orthotopic liver transplantation with and without aprotinin. Transplantation 1995;59:366-370.
12. Segal H, Hunt BJ, Cottam S, Downing A, Beard C, Francis JL, Potter D, et al. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin. Transplantation 1994;58:1356-1360.
13. Himmelreich G, Dooijwaard G, Breinl P, Bechstein WO, Neuhaus P, Kluft C, Reiss H. Evolution of urokinase plasminogen activator (uPA) and tissue type plasminogen activator (tPA) on orthotopic liver transplantation (OLT). Thromb Haemostas 1993; 69:56-59.
14. Dzik WH, Arkin CF, Jenkins RL, Stump DC. Fibrinolysis during liver transplantation in humans: role of tissue type plasminogen activator. Blood 1988;71:1090-1095.
15. Arnoux D, Boutiere B, Houvenaeghel M, Rousset-Rouviere A, Le Treut P, Sampol J. Intraoperative evolution of coagulation parameters and t-PA/PAI balance in orthotopic liver transplantation. Thromb Res 1989; 55:319-328.
16. Grosse H, Lobbes W, Frambach M, von Broen O, Ringe B, Barthels M. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss. Thromb Res 1991;63:287-297.
17. Bechstein WO, Riess H, Blumhardt G, Himmelreich G, Jochum M, Gerlach H, Rossaint R. Aprotinin in orthotopic liver transplantation. Semin Thromb Hemost 1993; 19:262-267.
18. Rang Y. Clinical use of synthetic antifibrinolytic agents during liver transplantation. Semin Thromb Hemost 1993; 19:258-261.
19. Velasco F, Villalba R, Fernandez M, De La Mata M, Roman J, Rubio V, Rufian S. Diminished anticoagulant and fibrinolytic activity following liver transplantation. Transplantation 1992;53:1256-1261.